On June 7th, Era Biology hosted a live webinar for Latin America. The webinar focuses on antimicrobial resistance problem. Since 2005, the antibiotic resistance rate of bacteria has been increasing...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
The 29th edition of Expomed Eurasia took place on March 17-19, 2022 in Istanbul, Turkey. With 600+ exhibitors from Turkey and around world & 19000 visitors only from Turkey and 5000 intern...
YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
FACIS Successfully Approved by Health Canada
We are glad to announce that the Full-Automatic Chemiluminescence Immunoassay System (FACIS), with its adaptable reagents the Aspergillus Galactomannan ...
The second National Academic Conference on Bacterial and Fungal Infections of Chinese Medical Association was successfully held in Guangzhou, July 29-31, 2022. The academic report of the conference...